X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2309) 2309
Patent (530) 530
Publication (367) 367
Newspaper Article (343) 343
Paper (278) 278
Book Review (112) 112
Book / eBook (76) 76
Conference Proceeding (72) 72
Magazine Article (59) 59
Book Chapter (56) 56
Trade Publication Article (35) 35
Dissertation (28) 28
Reference (7) 7
Video Recording (6) 6
Newsletter (5) 5
Streaming Audio (5) 5
Web Resource (4) 4
Report (3) 3
Compact Disc (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (744) 744
physics (708) 708
humans (648) 648
male (429) 429
female (392) 392
information storage (341) 341
middle aged (321) 321
information storage based on relative movement between recordcarrier and transducer (320) 320
experiment (296) 296
particle physics (284) 284
adult (282) 282
physics - high energy physics - experiment (279) 279
high energy physics - experiment (251) 251
gastroenterology & hepatology (250) 250
aged (200) 200
electricity (190) 190
performing operations (185) 185
transporting (185) 185
hadron-hadron scattering (167) 167
abridged index medicus (166) 166
appointments & personnel changes (162) 162
testing (153) 153
measuring (147) 147
nanotechnology (147) 147
manufacture or treatment of nanostructures (145) 145
measurement or analysis of nanostructures (145) 145
specific uses or applications of nanostructures (145) 145
basic electric elements (139) 139
hep (135) 135
executives (131) 131
article (129) 129
particle physics - experiment (127) 127
general tagging of cross-sectional technologies spanning over several sections of the ipc (118) 118
general tagging of new technological developments (118) 118
high energy physics (118) 118
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (118) 118
animals (117) 117
physics, particles & fields (115) 115
electric solid state devices not otherwise provided for (113) 113
semiconductor devices (113) 113
analysis (108) 108
measuring electric variables (108) 108
measuring magnetic variables (108) 108
technical subjects covered by former uspc (106) 106
risk factors (104) 104
b physics (98) 98
research (96) 96
liver (91) 91
treatment outcome (89) 89
hep-ex (85) 85
technical subjects covered by former us classification (85) 85
transplantation (81) 81
flavor physics (79) 79
elementary particles, quantum field theory (77) 77
quantum field theories, string theory (77) 77
prospective studies (74) 74
surgery (73) 73
decay (70) 70
liver transplantation (70) 70
luminosity (70) 70
prognosis (70) 70
officials and employees (68) 68
ex (67) 67
gastroenterology and hepatology (67) 67
adolescent (66) 66
veterans (66) 66
banking industry (65) 65
united-states (64) 64
classical and quantum gravitation, relativity theory (63) 63
inductances (63) 63
magnets (63) 63
quantum physics (63) 63
selection of materials for their magnetic properties (63) 63
transformers (63) 63
disease (62) 62
experimental results (62) 62
liver diseases (62) 62
psychiatry (62) 62
united states (62) 62
aged, 80 and over (61) 61
ptsd (61) 61
chemistry (59) 59
studies (59) 59
care and treatment (58) 58
cern lhc coll (58) 58
health aspects (58) 58
hepatotoxicity (57) 57
mortality (57) 57
hepatitis (56) 56
therapy (56) 56
adults (55) 55
nuclear experiment (55) 55
follow-up studies (54) 54
metallurgy (54) 54
mice (54) 54
oncology (54) 54
retrospective studies (54) 54
cp violation (53) 53
americans (52) 52
time factors (51) 51
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (43) 43
UTL at Downsview - May be requested (19) 19
UofT at Mississauga - Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Victoria University E.J. Pratt - Stacks (6) 6
Gerstein Science - Stacks (5) 5
Media Commons - Audio Visual (4) 4
Thomas Fisher Rare Book - Rare Book (3) 3
UofT at Scarborough - Stacks (3) 3
Art - Library use only (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
OISE - Stacks (2) 2
Royal Ontario Museum - Stacks (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
St. Michael's College (John M. Kelly) - 3rd Floor (2) 2
Trinity College (John W Graham) - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Faculty of Information - Stacks (1) 1
Mathematical Sciences - Stacks (1) 1
Music - Circulation Desk (1) 1
OISE - Reference (1) 1
Online Resources - Online (1) 1
Physics - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Regis College - Stacks (1) 1
St. Michael's College (John M. Kelly) - Audio Visual (1) 1
Trinity College (John W Graham) - Storage (1) 1
UofT at Mississauga - 1st Floor (1) 1
UofT at Scarborough - Withdrawn (1) 1
Victoria University CRRS - Library use only (1) 1
Victoria University E.J. Pratt - Oversize (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3415) 3415
French (127) 127
German (71) 71
Chinese (18) 18
Spanish (18) 18
Italian (15) 15
Portuguese (14) 14
Norwegian (4) 4
Catalan (3) 3
Japanese (2) 2
Korean (2) 2
Latin (1) 1
Russian (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology, ISSN 0016-5085, 2015, Volume 149, Issue 3, pp. 649 - 659
Background & Aims There are no effective and safe treatments for chronic hepatitis C virus (HCV) infection of patients who have advanced liver disease. Methods... 
Gastroenterology and Hepatology | Liver Transplantation | Decompensated Cirrhosis | Hepatitis C Virus Infection | Fibrosing Cholestatic Hepatitis | C INFECTION | TRANSPLANTATION PATIENTS | RECIPIENTS | INTERFERON | THERAPY | ADEFOVIR DIPIVOXIL | CIRRHOSIS | GENOTYPE 1 INFECTION | OUTCOMES | GASTROENTEROLOGY & HEPATOLOGY | United States | Humans | Middle Aged | Fluorenes - therapeutic use | Liver Cirrhosis - mortality | Hepacivirus - genetics | Male | Cholestasis, Intrahepatic - drug therapy | Hepatitis C, Chronic - complications | Hepatitis C, Chronic - mortality | Time Factors | Female | Fluorenes - adverse effects | Uridine Monophosphate - adverse effects | Benzimidazoles - adverse effects | Drug Therapy, Combination | Cholestasis, Intrahepatic - virology | Benzimidazoles - therapeutic use | Uridine Monophosphate - therapeutic use | Hepacivirus - drug effects | Liver Cirrhosis - drug therapy | Liver Cirrhosis - diagnosis | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Genotype | Treatment Outcome | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Disease Progression | Cholestasis, Intrahepatic - mortality | Hepacivirus - enzymology | Liver Cirrhosis - virology | Cholestasis, Intrahepatic - diagnosis | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Drug Combinations | Care and treatment | Liver diseases | Hepatitis C virus | Hepatitis C | Health aspects | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 27, pp. 2618 - 2628
Journal Article
by Gatsonis, Constantine A and Aberle, Denise R and Berg, Christine D and Black, William C and Church, Timothy R and Fagerstrom, Richard M and Galen, Barbara and Gareen, Ilana F and Goldin, Jonathan and Gohagan, John K and Hillman, Bruce and Jaffe, Carl and Kramer, Barnett S and Lynch, David and Marcus, Pamela M and Schnall, Mitchell and Sullivan, Daniel C and Sullivan, Dorothy and Zylak, Carl J and Cagnon, Christopher and Cody, Dianna and Fletcher, Glenn and Flynn, Michael J and Judy, Philip F and Kruger, Randell and Larke, Frederick J and McNitt-Gray, Michael and Payne, Thomas and Anthony Seibert, J and Wu, Xizeng and Abbott, Gerald and Amorosa, Judith K and Barr, Richard G and Boiselle, Phillip M and Chiles, Caroline and Clark, Robert and Coppage, Lynn and Falk, Robert and Fishman, Elliot K and Gemmel, David and Goldin, Jonathan G and Goodman, Eric and Hart, Eric M and Hazelton, Todd and Johnson, Elizabeth and Kazerooni, Ella and McComb, Barbara and McLennan, Geoffrey and Munden, Reginald F and Ravenel, James and Sullivan, Michael and Swensen, Stephen J and Torigian, Drew A and Vydareny, Kay H and Worrell, John A and Balkin, Peter and Fouad, Mona and Freedman, Matthew T and Garg, Kavita and Gelmann, Edward P and Gierada, David S and Hocking, William and Inampudi, Subbarao and Isaacs, Claudine and Kvale, Paul and Mann, Howard and Manor, William and Nath, Hrudaya and Reding, Douglas and Spizarny, David L and Strollo, Diane C and Waltz, John and Chen, Mei-Hsiu and Duan, Fenghai and Izmirilian, Grant and Pinsky, Paul and Prorok, Philip C and Miller, Anthony B and Edelman, Martin J and Evans, William K and Fontana, Robert S and Machtay, Mitchell and Clark, Kenneth W and Clingan, Kathy L and Ford, Melissa B and Márquez, Guillermo and Moore, Steven M and Ohan, Peter and Payne, Thomas J and Peace, Steven and Rosenbaum, Jennifer L and Barr, Richard and Black, William and Torigian, Drew and Vydareny, Kay and Worrell, John and Young, Robert C and Alberts, David and DeMets, David and Greenwald, Peter and ... and Natl Lung Screening Trial Res Team and National Lung Screening Trial Research Team
Radiology, ISSN 0033-8419, 01/2011, Volume 258, Issue 1, pp. 243 - 253
Journal Article
Gastroenterology, ISSN 0016-5085, 2015, Volume 148, Issue 1, pp. 108 - 117
Background & Aims Interferon alfa–based regimens used to treat recurrent hepatitis C virus (HCV) infection after liver transplantation are poorly tolerated,... 
Gastroenterology and Hepatology | Antiviral Agent | Clinical Trial | DAA | NS5B Polymerase Inhibitor | PLUS RIBAVIRIN | ANTIVIRAL THERAPY | EFFICACY | HCV GENOTYPE 1 | MULTICENTER EXPERIENCE | COMBINATION | RECIPIENTS | PEGYLATED INTERFERON | GRAFT-SURVIVAL | GASTROENTEROLOGY & HEPATOLOGY | DRUG-DRUG INTERACTIONS | Recurrence | Prospective Studies | Antiviral Agents - pharmacokinetics | Hepatitis C - drug therapy | Liver Transplantation - adverse effects | United States | Humans | Drug Resistance, Viral | Hepacivirus - genetics | Hepacivirus - pathogenicity | Male | RNA, Viral - blood | Viral Load | Time Factors | Ribavirin - pharmacokinetics | Female | Hepatitis C - complications | Uridine Monophosphate - adverse effects | Drug Therapy, Combination | Uridine Monophosphate - therapeutic use | Hepacivirus - drug effects | Liver Neoplasms - virology | Liver Cirrhosis - diagnosis | Antiviral Agents - therapeutic use | Carcinoma, Hepatocellular - diagnosis | Ribavirin - therapeutic use | Carcinoma, Hepatocellular - surgery | Genotype | Liver Neoplasms - surgery | Treatment Outcome | Carcinoma, Hepatocellular - virology | Biomarkers - blood | Spain | New Zealand | Hepatitis C - diagnosis | Pilot Projects | Liver Cirrhosis - virology | Liver Neoplasms - diagnosis | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Liver Cirrhosis - surgery | Uridine Monophosphate - pharmacokinetics | Sofosbuvir | Virus diseases | Relapse | Liver | Transplantation | Biological response modifiers | Drug therapy | Hepatitis C virus | Health aspects | Immunosuppressive agents | Ribavirin | Diseases | Index Medicus | Abridged Index Medicus
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 10/2018, Volume 113, Issue Supplement, p. S469
Journal Article
Liver Transplantation, ISSN 1527-6465, 04/2016, Volume 22, Issue 4, pp. 446 - 458
Daclatasvir (DCV) is a potent, pangenotypic nonstructural protein 5A inhibitor with demonstrated antiviral efficacy when combined with sofosbuvir (SOF) or... 
SURGERY | INTERFERON-ALPHA-2B | ANTIVIRAL THERAPY | RIBAVIRIN | COMBINATION | VIROLOGICAL RESPONSE | HCV INFECTION | TRANSPLANTATION | GENOTYPE 1 | PLUS SOFOSBUVIR | INHIBITOR | GASTROENTEROLOGY & HEPATOLOGY | COMPASSIONATE USE | Recurrence | Liver Transplantation - adverse effects | Compassionate Use Trials | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Imidazoles - administration & dosage | Male | Hepatitis C, Chronic - complications | Simeprevir - therapeutic use | Simeprevir - adverse effects | Simeprevir - administration & dosage | Ribavirin - administration & dosage | Female | Retrospective Studies | Imidazoles - therapeutic use | Sofosbuvir - adverse effects | Sofosbuvir - therapeutic use | Hepacivirus - isolation & purification | Liver Cirrhosis - etiology | Antiviral Agents - therapeutic use | Imidazoles - adverse effects | Ribavirin - therapeutic use | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Drug Therapy, Combination - methods | Sofosbuvir - administration & dosage | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Liver Cirrhosis - pathology | Liver Diseases - surgery | Aged | Index Medicus | Infectious Medicine | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Infektionsmedicin
Journal Article